by Syrma Johari MedTech | Nov 14, 2025 | Blog
Tariff engineering is the legitimate practice of designing a product, its components, or its classification to ensure that, upon import, it qualifies for a lower tariff rate. This is not tariff evasion—it is a deliberate, commercially sound, and technically defensible...
by Syrma Johari MedTech | Nov 14, 2025 | Blog
Medical devices are built on globally distributed value chains: for example, sensors from Japan, plastics from Mexico, electronics from Asia, final assembly in the U.S. or EU, and post-market service worldwide. For much of the last three decades, this ecosystem scaled...
by Syrma Johari MedTech | Nov 5, 2025 | Blog
Post-COVID, in vitro diagnostic (IVD) has transitioned from episodic use to being integral across precision medicine, preventive care, and consumer health. The pandemic drove unprecedented demand, with the global IVD market surging by 45.4% in value from 2019 to 2020....
by Syrma Johari MedTech | Oct 23, 2025 | Blog
In today’s high-stakes MedTech landscape, your supplier network directly reflects your product integrity, regulatory posture, and time-to-market reliability. For manufacturers of Class II and III devices, supplier non-conformance can trigger far more than a CAPA. It...
by Syrma Johari MedTech | Oct 16, 2025 | Blog
A practical guide to navigate complex global approval pathways for MedTech companies. Access the Full Guide Delayed time-to-market can translate directly into lost market revenue. Navigating global regulatory submissions has become a complex challenge for MedTech...
by Syrma Johari MedTech | Jul 8, 2025 | Blog
Medical device original equipment manufacturers (OEMs) are relying more than ever on contract manufacturing organizations (CMOs) to manage complex and capital-intensive manufacturing. Choosing the right medical device contract manufacturer is one of the most strategic...
